93188-01-3 Usage
General Description
Benzyl 2-carbamoylpyrrolidine-1-carboxylate is a chemical compound with the molecular formula C16H20N2O3. It is a derivative of pyrrolidine, a five-membered ring molecule containing one nitrogen atom. BENZYL 2-CARBAMOYLPYRROLIDINE-1-CARBOXYLATE is commonly used as a building block in organic synthesis and is often utilized in the pharmaceutical industry to create new drugs. It has potential applications in the production of various pharmaceutical agents, especially those related to treating neurodegenerative diseases and mental health conditions. Additionally, it may also have uses in the development of agriculture products and materials science. Overall, benzyl 2-carbamoylpyrrolidine-1-carboxylate is a versatile compound with important applications in the field of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 93188-01-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,1,8 and 8 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 93188-01:
(7*9)+(6*3)+(5*1)+(4*8)+(3*8)+(2*0)+(1*1)=143
143 % 10 = 3
So 93188-01-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H16N2O3/c14-12(16)11-7-4-8-15(11)13(17)18-9-10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H2,14,16)
93188-01-3Relevant articles and documents
INDUCIBLE NITRIC OXIDE SYNTHASE DIMERIZATION INHIBITORS
-
Page/Page column 66, (2010/11/08)
The present invention relates to compounds and methods useful as inhibitors of nitric oxide synthase. Certain compounds of the subject invention have the following structural formula: wherein T, X, and Y are independently selected from the group consisting of CR4, N, NR4, S, and O; U is selected from the group consisting of CR10 and N; V is selected from the group consisting of CR4 and N; W and W' are independently selected from the group consisting of CH2, CR7R8, NR9, O, N(O), S(O)q and C(O); n, m and p are independently an integer from 0 to 5; q is 0, 1, or 2; and other substituents are as defined herein. Other compounds of the subject invention have structural formulas as defined herein. Also disclosed herein are pharmaceutical compositions comprising the compounds of the subject invention
